Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00018-016-2200-7 http://scihub22266oqcxt.onion/10.1007/s00018-016-2200-7 C4887531!4887531!27048815     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cell+Mol+Life+Sci 2016 ; 73 (ä): 2269-84 Nephropedia Template TP {{tp|p=27048815|t=2016. Inhibition of regulated cell death by cell-penetrating peptides |pdf=|usr=}}{{27048815}} gab.com Text Inhibition of regulated cell death by cell-penetrating peptides JO: Cell Mol Life Sci http://www.kidney.de/pget.php?&tw=1&pmid=27048815 #FOAvip Development of the means to efficiently and continuously renew missing and non-functional proteins in diseased cells remains a major goal in modern molecular medicine. While gene therapy has the potential to achieve this, substantial obstacles must be overcome before clinical application can be considered. A promising alternative approach is the direct delivery of non-permeant active biomolecules, such as oligonucleotides, peptides and proteins, to the affected cells with the purpose of ameliorating an advanced disease process. In addition to receptor-mediated endocytosis, cell-penetrating peptides are widely used as vectors for rapid translocation of conjugated molecules across cell membranes into intracellular compartments and the delivery of these therapeutic molecules is generally referred to as novel prospective protein therapy. As a broad coverage of the enormous amount of published data in this field is unrewarding, this review will provide a brief, focused overview of the technology and a summary of recent studies of the most commonly used protein transduction domains and their potential as therapeutic agents for the treatment of cellular damage and the prevention of regulated cell death. Twit Text FOAVip Inhibition of regulated cell death by cell-penetrating peptides ????Cell Mol Life Sci http://www.kidney.de/pget.php?&tw=1&pmid=27048815 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27048815 #FOAvip English Wikipedia <ref>{{Cite pmid|27048815}}</ref> Inhibition of regulated cell death by cell-penetrating peptides #MMPMID27048815 Krautwald S; Dewitz C; Fändrich F; Kunzendorf U Cell Mol Life Sci 2016[]; 73 (ä): 2269-84 PMID27048815show ga Development of the means to efficiently and continuously renew missing and non-functional proteins in diseased cells remains a major goal in modern molecular medicine. While gene therapy has the potential to achieve this, substantial obstacles must be overcome before clinical application can be considered. A promising alternative approach is the direct delivery of non-permeant active biomolecules, such as oligonucleotides, peptides and proteins, to the affected cells with the purpose of ameliorating an advanced disease process. In addition to receptor-mediated endocytosis, cell-penetrating peptides are widely used as vectors for rapid translocation of conjugated molecules across cell membranes into intracellular compartments and the delivery of these therapeutic molecules is generally referred to as novel prospective protein therapy. As a broad coverage of the enormous amount of published data in this field is unrewarding, this review will provide a brief, focused overview of the technology and a summary of recent studies of the most commonly used protein transduction domains and their potential as therapeutic agents for the treatment of cellular damage and the prevention of regulated cell death. äInhibition of regulated cell death by cell-penetrating peptides (epmc).pdf DeepDyve Pubget Overpricing